Raymond James Financial Services Advisors, Inc. Eli Lilly & CO Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 290,327 shares of LLY stock, worth $217 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

290,327

Previous 270,986 7.14%

Holding current value

$217 Million

Previous $245 Million 4.84%

% of portfolio

0.35%

Previous 0.35%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$772.14 - $960.02 $14.9 Million - $18.6 Million	19,341 Added 7.14%	290,327 $257 Million
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $1.89 Million - $2.37 Million	-2,607 Reduced 0.95%	270,986 $245 Million
Q1 2024 Apr 22, 2024	BUY	$592.2 - $792.28 $7.78 Million - $10.4 Million	13,133 Added 5.04%	273,593 $213 Million
Q4 2023 Jan 16, 2024	BUY	$525.19 - $619.13 $9.4 Million - $11.1 Million	17,902 Added 7.38%	260,460 $152 Million
Q3 2023 Oct 24, 2023	BUY	$434.7 - $599.3 $3.13 Million - $4.31 Million	7,194 Added 3.06%	242,558 $130 Million
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $835,813 - $1.12 Million	2,383 Added 1.02%	235,364 $110 Million
Q1 2023 Apr 14, 2023	SELL	$310.63 - $364.82 $3.09 Million - $3.63 Million	-9,961 Reduced 4.1%	232,981 $80 Million
Q4 2022 Feb 08, 2023	SELL	$321.55 - $374.67 $2.23 Million - $2.6 Million	-6,946 Reduced 2.78%	242,942 $88.9 Million
Q3 2022 Oct 25, 2022	BUY	$296.48 - $337.87 $1.8 Million - $2.05 Million	6,055 Added 2.48%	249,888 $80.8 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $8.64 Million - $10.1 Million	30,997 Added 14.56%	243,833 $79.1 Million
Q1 2022 May 11, 2022	BUY	$234.69 - $291.66 $378,320 - $470,155	1,612 Added 0.76%	212,836 $61 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $1.27 Million - $1.57 Million	-5,629 Reduced 2.6%	211,224 $58.3 Million
Q3 2021 Nov 02, 2021	BUY	$221.6 - $272.71 $1.81 Million - $2.23 Million	8,162 Added 3.91%	216,853 $50.1 Million
Q2 2021 Aug 11, 2021	BUY	$180.55 - $233.54 $133,426 - $172,586	739 Added 0.36%	208,691 $47.9 Million
Q1 2021 May 14, 2021	BUY	$164.32 - $212.72 $1.48 Million - $1.91 Million	8,985 Added 4.52%	207,952 $38.9 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $252,309 - $333,866	1,934 Added 0.98%	198,967 $33.6 Million
Q3 2020 Nov 04, 2020	SELL	$146.22 - $169.13 $437,344 - $505,867	-2,991 Reduced 1.5%	197,033 $29.2 Million
Q2 2020 Jul 17, 2020	BUY	$136.42 - $164.18 $3.8 Million - $4.58 Million	27,878 Added 16.19%	200,024 $32.8 Million
Q1 2020 Apr 21, 2020	BUY	$119.05 - $147.35 $568,582 - $703,743	4,776 Added 2.85%	172,146 $23.9 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $212,236 - $262,873	-1,985 Reduced 1.17%	167,370 $22 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $1.09 Million - $1.19 Million	10,202 Added 6.41%	169,355 $18.9 Million
Q2 2019 Aug 06, 2019	BUY	$110.79 - $129.32 $209,836 - $244,932	1,894 Added 1.2%	159,153 $17.6 Million
Q1 2019 May 06, 2019	BUY	$111.31 - $131.02 $17.5 Million - $20.6 Million	157,259 New	157,259 $20.4 Million
Q4 2018 Feb 11, 2019	SELL	$105.9 - $118.64 $16.6 Million - $18.6 Million	-156,694 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $286,343 - $357,878	3,335 Added 2.17%	156,694 $16.8 Million
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $802,722 - $921,275	-10,604 Reduced 6.47%	153,359 $13.1 Million
Q1 2018 Apr 16, 2018	SELL	$74.21 - $87.6 $276,729 - $326,660	-3,729 Reduced 2.22%	163,963 $12.7 Million
Q4 2017 Feb 09, 2018	BUY	$81.94 - $87.89 $483,200 - $518,287	5,897 Added 3.64%	167,692 $14.2 Million
Q3 2017 Oct 26, 2017	SELL	$77.07 - $85.54 $754,669 - $837,607	-9,792 Reduced 5.71%	161,795 $13.8 Million
Q2 2017 Aug 15, 2017	BUY	N/A	171,587	171,587 $14.1 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account

Raymond James Financial Services Advisors, Inc. Eli Lilly & CO Transaction History